NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

DCVax-L + CI combo trial to target those non-mesenchymals makes a lot of sense to me. It might also serve to make the FDA feel better about approving DCVax-L for the whole ball of wax, because there is a plan in place that would build on it and fill in the gaps.

Kind of like ARGS bragging up their new lease for a mfg facility. It might take them years to get it up and running, but it also might make the FDA feel better about approving their product right now. Though I doubt it. But I think that is ARG's hope.

So also a convenient time for NWBO to show a follow-up plan regarding the whole ball of wax. Large scale Mfg is presumably already being addressed.